This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Bone marrow-derived mesenchymal stem cell
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Pancreatic cancer cells (KPC)
Pancreatic ductal epithelial cells (MPDC)
Plasma
Seminal plasma
Serum
By sample status
24 hr culture
72 hr culture
Co-cultured with erythropoietin
Normal
S. aureus-injected_24 hr
S. aureus-injected_4 hr
Transplant islets into mouse xenotransplantation
Transplant islets into mouse xenotransplantation-rejected
Vasectomy
Vasovasostomy
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
mmu-miR-2137
MIMAT0011213
0.0e+0
2.7e-2
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
3.2e-2
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
3.2e-2
microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
4.5e-2
2.0e-1
Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
2.9e-2
3.3e-1
Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
8.4e-8
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
7.9e-9
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
1.6e-4
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
2.0e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
1.1e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
1.9e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
2.1e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
3.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
9.4e-2
Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
4.8e-2
Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
4.1e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
0.0e+0
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
6.7e-16
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
Not available
19
/
0
/
19
mmu-miR-2137
MIMAT0011213
0.0e+0
2.6e-8
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
Not available
19
/
0
/
19
[1]